WW International, Inc. Common Stock

WW
$14.57 -0.30 (-2.02%)
Dividend Yield 2.06%
Payout Frequency Quarterly

Dividend History

Pay DateAmountEx-DateRecord Date
January 15, 2010$0.072009-12-282009-12-30
October 15, 2009$0.072009-09-282009-09-30
July 15, 2009$0.072009-06-262009-06-30
April 15, 2009$0.072009-03-272009-03-31
January 15, 2009$0.072008-12-262008-12-30

Dividends Summary

Company News

Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Benzinga • Vandana Singh • June 4, 2026

Weight Watchers expanded its GLP-1 weight-loss medication access by joining Eli Lilly's LillyDirect platform, combining branded medications with clinical support. Meanwhile, Eli Lilly partnered with Ascidian Therapeutics on RNA-based kidney disease treatments with potential deal value reaching $1.9 billion. Eli Lilly shares surged 5.13% to $1,134...

Weight Watchers Announces Leadership Transition and Board Updates
GlobeNewswire Inc. • Na • April 3, 2026

Weight Watchers (WW) announced that CEO Tara Comonte departed effective March 31, 2026. The company established an Office of the CEO led by CFO Felicia DellaFortuna and COO Jon Volkmann, with an interim CEO to be appointed. A Transition Committee was formed to oversee operations and conduct a comprehensive CEO search. The company reaffirmed its Q...

Amazon Is Now Offering Novo Nordisk's Wegovy Pill in Its Pharmacy. Here's How That Could Affect Hims & Hers, WW International, and GoodRx Holdings.
The Motley Fool • Reuben Gregg Brewer • February 6, 2026

Amazon has entered the GLP-1 weight loss drug market by offering Novo Nordisk's Wegovy pill through its pharmacy service at competitive prices ($25-$149 per month). This move could significantly impact competitors like Hims & Hers, WW International, and GoodRx, as Amazon leverages its 200 million Prime members and e-commerce platform. While the p...

Weight Watchers to Participate in Upcoming Investor Conferences
GlobeNewswire Inc. • Na • January 7, 2026

WW International announced its participation in two investor conferences in January 2026: the ICR Conference (January 12-13) in Orlando, FL and CJS Securities' 26th Annual New Ideas for the New Year (January 14) with a virtual fireside chat. The company will host investor meetings at both events.

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
Benzinga • Vandana Singh • January 5, 2026

Novo Nordisk launched its Wegovy weight loss pill in US pharmacies in December 2025 with competitive pricing starting at $149/month for self-pay patients. The pill demonstrated 17% average weight loss versus 3% for placebo. It's available through major retailers including CVS and Costco, as well as telehealth providers. Despite the positive produ...

Related Companies